News

Citadel Securities believes that the next major risk facing investors is the tightening of financial conditions, as the Federal Reserve may need to "quickly" raise interest rates to curb escalating inflation pressures. Nohshad Shah, head of fixed income sales for Citadel Securities in the Europe, Middle East, and Africa (EMEA) region, wrote in a client report that the combination of a massive generative AI investment cycle, tighter energy markets, and an increasingly strong labor market is amplifying the upside risks to economic growth and inflation. "The Fed's next move is most likely to be a rate hike... which may come soon."

BlockBeats news, on June 8, according to market data from a certain exchange, FTT surged over 77% in a short period before pulling back, and is now quoted at $0.335. Previously, Bloomberg reported that FTX co-founder Sam Bankman-Fried (SBF) has formally submitted a request for pardon to US President Trump, seeking to overturn his 25-year prison sentence related to the FTX fraud case.

Novo Nordisk's investigational drug CagriSema achieved its primary endpoints in three Phase 3 clinical trials. Data show that compared to placebo and Semaglutide, the drug led to statistically significant reductions in both glycated hemoglobin (HbA1c) and body weight among adults with type 2 diabetes.